CAS 76824-35-6
:Famotidine
- 3-[(2-Diaminomethyleneaminothiazol-4-yl)methylthio]-N-sulfamoylpropionamidine
- 3-[([2-[(Diaminomethylidene)amino]-1,3-thiazol-4-yl]methyl)sulfanyl]-N-sulfamoylpropanimidamide
- 3-[({2-[(Hydrazonomethyl)amino]thiazol-4-yl}methyl)thio]-N-sulfamoylpropionamidine
- 3-[[2-(Diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N′-sulfamoylpropanimidamide
- 3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)propanimidamide
- Agufam
- Amfamox
- Antodine
- Apo-Famotidine
- Apogastine
- Bestidine
- Brolin
- Cepal
- Digervin
- Dispromil
- Dispronil
- Durater
- Facid
- Fadin
- Fadine
- Fadyn
- Fagastine
- Famo
- FamoABZ
- Famocid
- Famodar
- Famodil
- Famodin
- Famodine
- Famogard
- Famogast
- Famolta
- Famonerton
- Famopsin
- Famos
- Famosan
- Famoser
- Famostagine-D
- Famotal
- Famotep
- Famotin
- Famotine
- Famowal
- Famox
- Famoxal
- Fanosin
- Fanox
- Farmotex
- Fenox
- Fibonel
- Fudone
- Fuweidin
- Ganor
- Gaster
- Gastridin
- Gastrion
- Gastro
- Gastrodomina
- Gastropen
- Ifada
- Kemofam
- Lecedil
- Logos
- Mosul
- Motiax
- Muclox
- N-(Aminosulfonyl)-3-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide
- Nevofam
- Nulcerin
- Panalba
- Pepcid
- Pepcidin
- Pepcidina
- Pepcidine
- Pepdif
- Pepdine
- Pepdul
- Pepfamin
- Peptan
- Peptec
- Peptifam
- Pepzan
- Purifam
- Quamatel
- Quamtel
- Restadin
- Rogasti
- Servipep
- Supertidine
- Tamin
- Topcid
- Ulcatif
- Ulcedine
- Ulceran
- Ulcetrax
- Ulcidine
- Ulcofam
- Ulfagel
- Ulfam
- Ulfamid
- Ulfinol
- Ulped
- Weimok
- [Amino-3-[[[2-[(Diaminomethylene)Amino]-4-Thiazolyl]-Methyl]Thio]Propylidene]
- Propanimidamide, 3-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)-
- Famotidine
- Famotidine (Patented-No Supply)
- See more synonyms
Famotidine
CAS:Formula:C8H15N7O2S3Purity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:337.44Famotidine, 98+%
CAS:A competitive histamine H2 receptor antagonist
Formula:C8H15N7O2S3Purity:98+%Molecular weight:337.45Famotidine
CAS:FamotidineFormula:C8H15N7O2S3Purity:99.7%Color and Shape:White. To. Off-WhiteMolecular weight:337.04494FAMOTIDINE FOR SYSTEM SUITABILITY CRS
CAS:FAMOTIDINE FOR SYSTEM SUITABILITY CRSFormula:C8H15N7O2S3Molecular weight:337.4454Famotidine
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C8H15N7O2S3Color and Shape:PowderMolecular weight:337.45Famotidine
CAS:Famotidine, a histamine H2-blocker, curbs gastric acid production, lowering volume and acidity.Formula:C8H15N7O2S3Purity:98.93% - 99.91%Color and Shape:White To Off-White Crystalline PowderMolecular weight:337.453-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide
CAS:Formula:C8H15N7O2S3Purity:97%Color and Shape:SolidMolecular weight:337.4454Ref: IN-DA003QKN
1g24.00€5g52.00€15g106.00€1kgTo inquire25g129.00€2kgTo inquire100g297.00€500gTo inquireFamotidine
CAS:Formula:C8H15N7O2S3Purity:≥ 98.0%Color and Shape:White to off-white powderMolecular weight:337.45Famotidine-d4 (Major)
CAS:Controlled ProductApplications Famotidine-d4 is the labeled analogue of Famotidine (F102250), a histamine H2-receptor antagonist. Antiulcerative.
References Takeda, M., et al.: Arzneim.-Forsch., 32, 734 (1982); Miwa, M., et al.: J. Clin. Pharmacol. Ther. Toxicol., 22, 214 (1984); Takabatke, T., et al.: Eur. J. Clin. Pharmacol., 28, 327 (1985)Formula:C8H11D4N7O2S3Color and Shape:NeatMolecular weight:341.47Famotidine
CAS:Controlled ProductApplications Histamine H2-receptor antagonist. Antiulcerative.
References Takeda, M., et al.: Arzneim.-Forsch., 32, 734 (1982), Miwa, M., et al.: J. Clin. Pharmacol. Ther. Toxicol., 22, 214 (1984), Takabatke, T., et al.: Eur. J. Clin. Pharmacol., 28, 327 (1985),Formula:C8H15N7O2S3Color and Shape:White To Off-WhiteMolecular weight:337.45Famotidine
CAS:Famotidine is a selective histamine H2-receptor antagonist used in the treatment of gastric hypersecretory disorders. Famotidine is effective in the treatment of duodenal and gastric ulcers, particularly when they are caused by the prolonged use of nonsteroidal antiinflammatory drugs (NSAIDs). To improve retention in the stomach, famotidine has experimentally been formulated as buoyant tablets that remained floating for up to 10 hours in vitro (Jaimini, 2007).
Formula:C8H15N7O2S3Purity:Min. 98 Area-%Color and Shape:White PowderMolecular weight:337.45 g/mol3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide
CAS:Formula:C8H15N7O2S3Purity:97%Molecular weight:337.44















